Samlyn Capital, LLC

SEC CIK: 0001421097
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CCCC holding history

C4 Therapeutics, Inc. in every 13F filed by Samlyn Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CCCC overview All 13F holders of CCCC Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of CCCC by Samlyn Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−3,015,139−100.0%	Sold out	Holders
Q1 2025	3,015,139	$4.82M	0.1%	−4,319−0.1%	Reduced	Holders
Q4 2024	3,019,458	$10.9M	0.2%	+3,019,458	New	Holders